Koen Raemdonck

Koen Raemdonck (1981) obtained a PhD in Pharmaceutical Sciences in 2009 at Ghent University, Belgium. In 2016, he was appointed as Assistant Professor at the Ghent Research Group on Nanomedicines where he was promoted to Full Professor in 2021. He (co-)authored >85 peer reviewed publications and is listed as inventor on 7 (pending) patent applications. Since 2011, he has been promotor and co-promotor of 14 successfully defended PhD theses at Ghent University. Currently, Prof. Raemdonck is a member of the Executive Council of the recently established Controlled Release Society (CRS) BeNeLux and France Local Chapter as well as group leader and Steering Committee member within the Cancer Research Institute Ghent (CRIG). The research of Prof. Raemdonck is mainly focused on exploring novel bio-inspired approaches for delivery of macromolecular therapeutics across intra-and extracellular biological barriers. His expertise includes the design and optimization of nanoformulations for RNA therapeutics and the detailed assessment of their behavior both in extracellular fluids and inside cells. For his work, Prof. Raemdonck has received several awards, including the T. Nagai Postdoctoral Research Achievement Award in 2016. To continue his research on inhalation therapy of RNA drugs he was recently awarded a prestigious ERC Consolidator Grant in 2020.